Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Italy Clear all

187 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20032
20043
20052
20069
20072
20088
20099
20104
20116
20128
20137
20148
201512
20164
20175
201810
201914
20208
202114
202214
20237
20247
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Terminated31
Active, not recruiting26
Recruiting15
Unknown status13
Not yet recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company17
AstraZeneca14
Novartis Pharmaceuticals13
Bristol-Myers Squibb11
Hoffmann-La Roche9
Pfizer9
ETOP IBCSG Partners Foundation7
European Organisation for Research and Treatment of Cancer - EORTC6
Fondazione Ricerca Traslazionale6
GlaxoSmithKline5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung187
Lung Neoplasms34
Neoplasms16
Melanoma10
Neoplasm Metastasis9
Breast Neoplasms7
Brain Neoplasms6
Head and Neck Neoplasms6
Adenocarcinoma of Lung5
Carcinoma5

Trials

Showing 1 to 25 of 187. Each trial links to its page on Pharma Observatory.

87 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.